scholarly journals Anticoagulants decrease the risk for catheter‐related venous thrombosis in patients with chronic intestinal failure: A long‐term cohort study

2021 ◽  
Author(s):  
Veerle ELM Gillis ◽  
Thijs Houdt ◽  
Yannick Wouters ◽  
Geert JA Wanten
Keyword(s):  
Cohort Study ◽  
Venous Thrombosis ◽  
Intestinal Failure

Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis: Results of a population-based cohort study

2013 ◽  
Vol 131 (6) ◽  
pp. 497-501 ◽  
Author(s):  
Hilde S. Wik ◽  
Anne F. Jacobsen ◽  
Morten W. Fagerland ◽  
Leiv Sandvik ◽  
Per Morten Sandset
Keyword(s):  
Cohort Study ◽  
Venous Thrombosis ◽  
Population Based ◽  
Incidence Of Cancer ◽  
Long Term Mortality

Central venous thrombosis in children with intestinal failure on long-term parenteral nutrition

2016 ◽  
Vol 51 (5) ◽  
pp. 790-793 ◽  
Author(s):  
Jessica Gonzalez-Hernandez ◽  
Yahya Daoud ◽  
Jennifer Styers ◽  
Janna M. Journeycake ◽  
Nandini Channabasappa ◽  
...  
Keyword(s):  
Parenteral Nutrition ◽  
Venous Thrombosis ◽  
Intestinal Failure ◽  
Central Venous ◽  
Central Venous Thrombosis

Idiopathic venous thrombosis

2006 ◽  
Vol 26 (01) ◽  
pp. 52-54 ◽  
Author(s):  
P. A. Kyrle
Keyword(s):  
Chronic Disease ◽  
Venous Thrombosis ◽  
Vitamin K ◽  
Clinical Benefit ◽  
Plasma Levels ◽  
Vitamin K Antagonists ◽  
Antithrombin Deficiency ◽  
Optimal Duration ◽  
Risk Of Treatment

SummaryVenous thrombosis is a chronic disease with a recurrence rate of approximately 30% within 5-8 years. The optimal duration of secondary thromboprophylaxis in these patients entails balancing the risk of recurrence against the risk of treatment-associated bleeding. There is agreement that patients with a first idiopathic venous thrombosis should receive vitamin K antagonists for at least 3-6 months. Convincing trials showing a clinical benefit in terms of morbidity or mortality with respect to expansion of anticoagulation beyond 6 months are lacking. Nevertheless, some subgroups of patients with venous thrombosis may benefit from indefinite anticoagulation. Thus, patients with antithrombin deficiency, combined or homozygous defects, more than one unprovoked episode of thrombosis, the lupus anticoagulant or high factor VIII plasma levels are good candidates for long-term prevention.

Author response for "The Effect Of Fall Biomechanics On Risk For Hip Fracture In Older Adults: A Cohort Study Of Video‐Captured Falls In Long‐Term Care"

2020 ◽  
Author(s):  
Yijian Yang ◽  
Vicki Komisar ◽  
Nataliya Shishov ◽  
Bryan Lo ◽  
Alexandra MB Korall ◽  
...  
Keyword(s):  
Older Adults ◽  
Cohort Study ◽  
Hip Fracture ◽  
Long Term Care ◽  
Author Response ◽  
Term Care
Sign in / Sign up

Export Citation Format

Share Document